UNH Exits Select Medicare Advantage Plans for 2027 Amid Cost Pressure

Zacks
Zacks에서 열기
UNH Exits Select Medicare Advantage Plans for 2027 Amid Cost Pressure

UnitedHealth Group Incorporated UNH is scaling back parts of its Medicare Advantage (MA) business for 2027 as elevated medical costs and utilization continue to pressure profitability. Per Bloomberg, UnitedHealthcare will discontinue plans covering about 390,000 members next year. The move reflects a more selective approach as the insurer focuses on improving the economics of its Medicare business.

The retrenchment is part of a broader industry reset, with insurers placing greater emphasis on plan-level profitability rather than maximizing enrollment. Reuters reported that UnitedHealthcare plans to exit locations where it has a higher concentration of preferred provider organization (PPO) plans, which offer broader out-of-network access but can carry higher costs.

For UNH, reducing exposure to less profitable plans could strengthen returns in Medicare Advantage as medical cost trends remain elevated. Beyond portfolio changes, UNH plans to invest nearly $1.5 billion in AI-related initiatives in 2026, aiming to improve productivity and reduce administrative burden. The company is also shifting toward narrower-network offerings. UnitedHealthcare said that 66% of members will have access to both health maintenance organization (HMO) and PPO plans in 2027, compared with 70% in 2026, according to Reuters.

Still, the strategy comes with a membership trade-off, as some displaced members could move to competitors instead of remaining within UnitedHealthcare. However, prioritizing sustainable margins over membership growth could support UNH’s earnings recovery. With the MA market facing persistent cost and reimbursement challenges, tighter plan selection could help the company build a healthier membership mix and improve Medicare Advantage profitability while preserving exposure to the market’s long-term growth opportunity.

How Are Competitors Faring?

Some of UNH’s major competitors in the healthcare service provider space are Humana Inc. HUM and Centene Corporation CNC.

Humana is also pruning its Medicare Advantage portfolio for 2027, with exits expected to affect roughly 600,000 members. The insurer is prioritizing stronger-performing plans and value-based care exposure, aiming to protect profitability while redirecting affected members toward other HUM plans.

Centene is taking a selective approach to Medicare Advantage for 2027. Per Becker’s Payer Issues, CNC’s Wellcare is reducing its plan lineup and exiting Hawaii, Oklahoma and Tennessee, while retaining Special Needs Plans in Nevada and Ohio as it refines strategy.

UnitedHealth’s Price Performance, Valuation & Estimates

Shares of UNH have gained 32.2% over the past six months compared with the industry’s rise of 32.1%.

Zacks Investment Research
Image Source: Zacks Investment Research

From a valuation standpoint, UnitedHealth trades at a forward price-to-earnings ratio of 16.98, above the industry average of 14.93. UNH carries a Value Score of B.

Zacks Investment Research
Image Source: Zacks Investment Research

The Zacks Consensus Estimate for UnitedHealth’s 2026 earnings is pegged at $19.85 per share, implying 21.4% growth from the year-ago period.

Zacks Investment Research
Image Source: Zacks Investment Research

UNH stock currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This innovative software-as-a-service firm upped its user base +22% year over year. That rate is increasing and margins are expanding as AI efficiencies take effect. Of course, all our elite picks aren't winners, but this one could far surpass earlier Zacks' Stocks Set to Double like D-Wave Quantum, which shot up +680.1%.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
UnitedHealth Group Incorporated (UNH): Free Stock Analysis Report
 
Humana Inc. (HUM): Free Stock Analysis Report
 
Centene Corporation (CNC): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research